These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9258425)

  • 1. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant.
    Djordjevic SP; Eamens GJ; Romalis LF; Nicholls PJ; Taylor V; Chin J
    Aust Vet J; 1997 Jul; 75(7):504-11. PubMed ID: 9258425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and mucosal antibody responses against Mycoplasma hyopneumoniae following intraperitoneal vaccination and challenge of pigs with M hyopneumoniae.
    Sheldrake RF; Romalis LF; Saunders MM
    Res Vet Sci; 1993 Nov; 55(3):371-6. PubMed ID: 8284503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
    Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
    Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs.
    Thacker EL; Thacker BJ; Kuhn M; Hawkins PA; Waters WR
    Am J Vet Res; 2000 Nov; 61(11):1384-9. PubMed ID: 11108184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and systemic immune responses in pigs intramuscularly injected with an inactivated Mycoplasma hyopneumoniae vaccine.
    Marchioro SB; Maes D; Flahou B; Pasmans F; Del Pozo Sacristán R; Vranckx K; Melkebeek V; Cox E; Wuyts N; Haesebrouck F
    Vaccine; 2013 Feb; 31(9):1305-11. PubMed ID: 23306368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
    Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
    Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
    Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
    Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.
    Marchioro SB; Sácristan Rdel P; Michiels A; Haesebrouck F; Conceição FR; Dellagostin OA; Maes D
    Vaccine; 2014 Aug; 32(36):4689-94. PubMed ID: 24909331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro comparisons of spray-drying and solvent- evaporation preparation of microencapsulated Mycoplasma hyopneumoniae for use as an orally administered vaccine for pigs.
    Lin JH; Pan MJ; Liao CW; Weng CN
    Am J Vet Res; 2002 Aug; 63(8):1118-23. PubMed ID: 12171164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against enzootic pneumonia of pigs: intraperitoneal inoculation with live LKR strain of Mycoplasma hyopneumoniae.
    Lloyd LC; Cottew GS; Anderson DA
    Aust Vet J; 1989 Jan; 66(1):9-12. PubMed ID: 2930394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae.
    Thacker EL; Thacker BJ; Young TF; Halbur PG
    Vaccine; 2000 Jan; 18(13):1244-52. PubMed ID: 10649626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal vaccination of pigs to control Mycoplasma hyopneumoniae.
    Sheldrake RF; Gardner IA; Saunders MM; Romalis LF
    Res Vet Sci; 1991 Nov; 51(3):285-91. PubMed ID: 1780583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine.
    Shimoji Y; Oishi E; Muneta Y; Nosaka H; Mori Y
    Vaccine; 2003 Jan; 21(5-6):532-7. PubMed ID: 12531653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine.
    Okamba FR; Arella M; Music N; Jia JJ; Gottschalk M; Gagnon CA
    Vaccine; 2010 Jul; 28(30):4802-9. PubMed ID: 20472025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a sIgA-ELISA method for differentiation of Mycoplasma hyopneumoniae infected from vaccinated pigs.
    Bai Y; Gan Y; Hua LZ; Nathues H; Yang H; Wei YN; Wu M; Shao GQ; Feng ZX
    Vet Microbiol; 2018 Sep; 223():86-92. PubMed ID: 30173757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of vaccination with culture supernate of M. hyopneumoniae against experimental infection in pigs.
    Okada M; Asai T; Ono M; Sakano T; Sato S
    J Vet Med B Infect Dis Vet Public Health; 2000 Sep; 47(7):527-33. PubMed ID: 11048434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mycoplasma hyopneumoniae plasma membrane as a vaccine against porcine enzootic pneumonia.
    Kobisch M; Quillien L; Tillon JP; Wróblewski H
    Ann Inst Pasteur Immunol; 1987; 138(5):693-705. PubMed ID: 3440060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
    Park SJ; Seo HW; Park C; Chae C
    Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of a live attenuated Mycoplasma hyopneumoniae vaccine with an ISCOM-matrix adjuvant in pigs.
    Xiong Q; Wei Y; Feng Z; Gan Y; Liu Z; Liu M; Bai F; Shao G
    Vet J; 2014 Feb; 199(2):268-74. PubMed ID: 24314715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoblotting analysis of antibody response in swine experimentally inoculated with Mycoplasma hyopneumoniae.
    Mori Y; Hamaoka T; Sato S; Takeuchi S
    Vet Immunol Immunopathol; 1988 Oct; 19(3-4):239-50. PubMed ID: 3252616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.